AABB Releases New Resources and Initiatives For its Certified Advanced Biotherapies Professional (CABP) Program

The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce several new offerings as part of its Certified Advanced Biotherapies Professional (CABP)

May 1, 2024

Bethesda, MD - The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce several new offerings as part of its Certified Advanced Biotherapies Professional (CABP) credentialing program. These updates, released to make the CABP program more accessible to biotherapies professionals and organizations, include:

  • CABP Sample Exam Question Sets

Developed to help candidates prepare for the CABP exam, AABB released two Sample Exam Questions sets. Each set includes 100 downloadable, printable sample questions that cover content across the exam’s seven domains, as well as an answer key with detailed rationales for each question. Questions Set 1, Questions Set 2 and a bundle of both sets are now available for purchase on the AABB store.

  • CABP Corporate Bundles

In response to increasing demand from organizations in the field, and to better support them in expanding the qualifications of their workforce, AABB is now offering CABP corporate bundles. Usually priced at $395 for AABB members and $495 for non-members, CABP exam fees are now being offered at a preferential rate for organizations registering multiple applicants. Discount levels available on enquiry.

About the CABP

AAAB’s CABP was developed in response to industry challenges associated with identifying and retaining qualified employees involved with biotherapies. It is a mark of distinction benefiting the entire field by establishing minimum standards of competence, identifying proficient professionals, and advancing safety and quality. Candidates must meet pre-requisites and obtain a passing grade on the 24/7 on-demand, computer-based online exam, demonstrating their competence in seven key domains:

  • Biotherapies in the Patient Care Ecosystem
  • Biotherapies Science and Ethics
  • Operations and Equipment
  • Biotherapies Development Lifecycle
  • Manufacturing
  • Quality Systems
  • The Regulatory Environment

The first cohort of CABPs was certified in December 2022, and there are now more than 125 CABPs in over ten countries worldwide. The full CABP registry is available for viewing on the AABB website. For more information on the CABP, eligibility and how to apply, visit www.aabb.org/cabp. Enquiries concerning CABP corporate bundles should be directed to: Becca Newburg, AABB Sales and Business Development Manager, at bnewburg@aabb.org.

About AABB

AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively to advance the field by developing and delivering standards, accreditation, and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available, and effective worldwide. For more information, visit www.aabb.org.

4550 Montgomery Avenue Suite 700, North Tower Bethesda, MD 20814
301.907.6977 www.aabb.org

###